Unusual radiologic manifestation of pseudoprogression in pulmonary metastases after durvalumab treatment in metastatic bladder urothelial cancer
Author:
Affiliation:
1. Department of Radiology, Gil Medical CenterGachon University College of Medicine Incheon South Korea
2. Division of Medical Oncology, Department of Internal Medicine, Gil Medical CenterGachon University College of Medicine Incheon South Korea
Publisher
Wiley
Subject
Pulmonary and Respiratory Medicine,Oncology,General Medicine
Link
https://onlinelibrary.wiley.com/doi/pdf/10.1111/1759-7714.12994
Reference8 articles.
1. Pseudoprogression and hyperprogression after checkpoint blockade
2. Immune Checkpoint Inhibitor Cancer Therapy: Spectrum of Imaging Findings
3. Peritumoural ground-glass opacity associated with tumour pseudoprogression in a patient with non-small cell lung cancer treated with nivolumab
4. Nivolumab-induced organizing pneumonia in a melanoma patient
5. Organizing Pneumonia Induced by Nivolumab in a Patient with Metastatic Melanoma
Cited by 7 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Radiological assessment of immunotherapy effects and immune checkpoint‐related pneumonitis for lung cancer;Journal of Cellular and Molecular Medicine;2023-07-31
2. Pseudoprogression in lung cancer patients treated with immunotherapy;Critical Reviews in Oncology/Hematology;2022-01
3. Case Report: Pseudoprogression With Nivolumab and Bevacizumab Followed by Recurrent Immune-Related Pneumonitis in Urothelial Carcinoma With Lung Metastasis;Frontiers in Oncology;2021-02-02
4. Behind a personalized therapy with immune check-point inhibitors in metastatic bladder cancer: ready for a primetime?;Translational Andrology and Urology;2020-12
5. Pseudoprogression and hyperprogression in lung cancer: a comprehensive review of literature;Journal of Cancer Research and Clinical Oncology;2020-08-28
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3